Touchstone Innovations appeared to be the Corporate Investor, which was created in 2001. The venture was found in Europe in United Kingdom. The main department of described Corporate Investor is located in the London.
The important activity for fund was in 2017. The fund is generally included in 2-6 deals every year. Opposing the other organizations, this Touchstone Innovations works on 18 percentage points less the average amount of lead investments. The real fund results show that this Corporate Investor is 52 percentage points more often commits exit comparing to other companies. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2019.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. The fund has exact preference in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Cell Medica, WaveOptics, Pulmocide. Among the most successful fund investment fields, there are Transportation, Commercial.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the Touchstone Innovations, startups are often financed by Nesta Ventures, Pitch@Palace, Cambridge Angels group. The meaningful sponsors for the fund in investment in the same round are Mercia Technologies, Draper Esprit, Worldpay. In the next rounds fund is usually obtained by IP Group Plc, Robert Bosch Venture Capital, Octopus Ventures.
Related Funds
Fund Name | Location |
Bincot | - |
CanCode | - |
Commodore Capital | New York, New York, United States |
Concord Partners | Massachusetts, United States, Wellesley |
Emeraude Suisse Capital | Geneva, Geneve, Switzerland |
Emurgo | Japan, Tokyo |
Genie Asset Management | - |
Hacking Health Accelerator | Canada, Montréal, Quebec |
Hangxin Investment | China, Shanghai |
Innova Kapital | England, London, United Kingdom |
Kissei Pharmaceutical | Japan, Matsumoto, Nagano Prefecture |
MEST Express accelerator | Accra, Ghana, Greater Accra |
Nikko Antfactory | - |
Ontario Pension Board | Canada, Ontario, Toronto |
Redwood Trust | California, Mill Valley, United States |
ShenZhen (SZSE) | China, Guangdong, Shenzhen |
Tokyo Commodity Exchange | - |
Trends Media | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
SAM Labs | $6M | 14 Nov 2017 | London, England, United Kingdom | ||
Oxford Biotrans | $2M | 10 Oct 2017 | Oxford, England, United Kingdom | ||
WaveOptics | $16M | 17 Jul 2017 | United Kingdom, England | ||
Yoyo Wallet | $16M | 26 Jun 2017 | London, England, United Kingdom | ||
Impression Technologies | $4M | 21 Jun 2017 | United Kingdom, Coventry | ||
Cardian | $2M | 06 Apr 2017 | London, England, United Kingdom | ||
Pulmocide | $30M | 20 Mar 2017 | London, England, United Kingdom | ||
Kuur Therapeutics | $82M | 15 Mar 2017 | London, England, United Kingdom | ||
Garrison Technology | $16M | 06 Mar 2017 | London, England, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
SAM Labs | $6M | 14 Nov 2017 | London, England, United Kingdom | ||
Oxford Biotrans | $2M | 10 Oct 2017 | Oxford, England, United Kingdom | ||
WaveOptics | $16M | 17 Jul 2017 | United Kingdom, England | ||
Yoyo Wallet | $16M | 26 Jun 2017 | London, England, United Kingdom | ||
Impression Technologies | $4M | 21 Jun 2017 | United Kingdom, Coventry | ||
Cardian | $2M | 06 Apr 2017 | London, England, United Kingdom | ||
Pulmocide | $30M | 20 Mar 2017 | London, England, United Kingdom | ||
Kuur Therapeutics | $82M | 15 Mar 2017 | London, England, United Kingdom | ||
Garrison Technology | $16M | 06 Mar 2017 | London, England, United Kingdom |